Arizona
Prescription drug spending and prescribing in Arizona, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $5.4B for prescriptions written in Arizona, the 17th most of 52 states and territories, and 4.1% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $5.4B
- Medicaid drugs, 2025: $2.1B
- Opioid share of claims: 4.1%
- Life-science raises, 2 years: $205M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Arizona | United States | Difference |
|---|---|---|---|
| Opioids | 4.1% | 3.5% | +15% |
| Antibiotics | 5.0% | 4.4% | +13% |
| Antipsychotics | 1.7% | 1.7% | -5% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Arizona's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Liothyronine Sodium | 2.5× | 33,579 |
| Progesterone, Micronized | 2.1× | 24,949 |
| Oxycodone Myristate | 2.1× | 13,600 |
| Morphine Sulfate | 1.8× | 83,437 |
| Oxycodone Hcl | 1.8× | 302,200 |
| Insulin Glargine/Lixisenatide | 1.7× | 8,252 |
| Sodium Zirconium Cyclosilicate | 1.6× | 9,645 |
| Acyclovir | 1.6× | 57,709 |
| Thyroid,pork | 1.6× | 13,485 |
| Flecainide Acetate | 1.6× | 36,325 |
Biggest Medicaid Drugs
What Arizona's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
29 Form D raises by companies based in Arizona in the last two years; the 10 largest. See all raises- GT MEDICAL TECHNOLOGIES, INC.$53M · Other health care · Mar 3, 2025
- GT MEDICAL TECHNOLOGIES, INC.$50M · Other health care · Jul 22, 2026
- EvolvedMD, Inc.$29M · Other health care · Jul 22, 2025
- HealthyU Family Medicine Holdings, LLC$25M · Hospitals and physicians · Sep 23, 2025
- CND Life Sciences, Inc.$9M · Biotech · Mar 6, 2025
- RGV Hospital Holdings, LLC$9M · Hospitals and physicians · Oct 15, 2025
- Avery Therapeutics, Inc.$8M · Biotech · Sep 21, 2026
- CND Life Sciences, Inc.$6M · Biotech · Jun 16, 2026
- TruLite Health, Inc.$3M · Other health care · Nov 25, 2024
- Captiox, LLC$2M · Other health care · Aug 14, 2026
State Attorney General Health-Care Cases
Antitrust cases Arizona joined, newest first; see every case- Plaintiff States and FTC v. CVET TOPCO, L.P. et al.2026 · Pending
- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
- Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL…2002 · Settled
Other States
Alabama · Alaska · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG